Raymond James Financial Services Advisors’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $634K | Sell |
22,408
-4
| -0% | -$113 | ﹤0.01% | 2454 |
|
|
2024
Q2 | $591K | Buy |
22,412
+2,363
| +12% | +$62.3K | ﹤0.01% | 2407 |
|
|
2024
Q1 | $609K | Buy |
20,049
+118
| +0.6% | +$3.58K | ﹤0.01% | 2372 |
|
|
2023
Q4 | $560K | Hold |
19,931
| – | – | ﹤0.01% | 2331 |
|
|
2023
Q3 | $541K | Sell |
19,931
-500
| -2% | -$13.6K | ﹤0.01% | 2274 |
|
|
2023
Q2 | $628K | Buy |
+20,431
| New | +$628K | ﹤0.01% | 2206 |
|
|
2022
Q1 | – | Sell |
-5,194
| Closed | -$207K | – | 3358 |
|
|
2021
Q4 | $207K | Buy |
+5,194
| New | +$207K | ﹤0.01% | 2951 |
|